Substance abuse and suicidality in schizophrenia: A common risk factor linked to impulsivity

Psychiatry Research

Volumn 102, Issue 1, 2001, Pages 65-72

  Gut Fayand, Anne ^a   Dervaux, Alain ^a   Olié, Jean Pierre ^a   Lôo, Henri ^a   Poirier, Marie France ^a   Krebs, Marie Odile ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

Anhedonia; Impulsivity; Reward system; Self medication; Suicide

Indexed keywords

ADULT; ANALYTIC METHOD; ANHEDONIA; ARTICLE; CLINICAL ARTICLE; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG DEPENDENCE; FEMALE; HUMAN; IMPULSIVENESS; MALADJUSTMENT; MALE; ONSET AGE; PERSONALITY; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOLOGIC TEST; QUESTIONNAIRE; RISK FACTOR; SCHIZOPHRENIA; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; SYMPTOMATOLOGY;

ADULT; COGNITION DISORDERS; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; SUICIDE, ATTEMPTED;

EID: 0035837411     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(01)00250-5     Document Type: Article

References (39)

1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., revised :1987;American Psychiatric Press, Washington, DC.
2. Barratt E.S., Stanford M.S. Impulsiveness. Costello C.G., Personality Characteristics of the Personality Disorders. 1995;91-119 John Wiley & Sons, Inc, New York. chapter 4.
3. Baxter D., Appleby L. Case register study of suicide risk in mental disorders. British Journal of Psychiatry. 175:1999;322-326.
4. Baylé F.J., Bourdel M.C., Caci H., Gorwood P., Chignon J.M., Ades J., Lôo H. Validation de la traduction Française de l'échelle d'impulsivité de Barrat (BIS 10). Canadian Journal of Psychiatry. 45:2000;156-165. [Factor analysis of French translation of the Barratt Impulsivity Scale (BIS-10).].
5. Blanchard J.J., Brown S.A., Horan W.P., Sherwood A.R. Substance use disorders in schizophrenia: review, integration and a proposed model. Clinical Psychology Review. 20:2000;207-234.
6. Brady K., Anton R., Ballenger J.C., Lydiard B., Adinoff B., Selander J. Cocaine abuse among schizophrenic patients. American Journal of Psychiatry. 147:1990;1164-1167.
7. Buckley P.F. Substance abuse in schizophrenia: a review. Journal of Clinical Psychiatry. 59:1994;26-30.
8. Chapman L.J., Chapman J.P., Raulin M.L. Scale for Physical and Social Anhedonia. Journal of Abnormal Psychology. 4:1976;374-382.
9. Cuffel B.J., Chase P. Remission and relapse of substance use disorders in schizophrenia. Results from a one year prospective study. Journal of Nervous and Mental Disease. 182:1994;342-348.
10. DeQuardo J.R., Carpenter C.F., Tandon R. Patterns of substance abuse in schizophrenia: nature and significance. Journal of Psychiatric Research. 28:1994;267-275.
11. Dervaux A., Baylé F.J., Laqueille X., Bourdel M.C., Le Borgne M.H., Olié J.P., Krebs M.O. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia? American Journal of Psychiatry. 158:2001;492-494.
12. DiChiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences USA. 85:1988;5274-5278.
13. Dixon L., Haas G., Weiden P.J., Sweeney J., Frances A.J. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. American Journal of Psychiatry. 148:1991;224-240.
14. Duaux E., Griffon N., Gorwood P., Sautel F., Sokoloff P., Schwartz J.C., Ades L., Lôo H., Poirier M.F. A polymorphism of dopamine D3 receptor gene associated with opiate dependence. Molecular Psychiatry. 3:1998;333-336.
15. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robledo P., Robbins T.W. Associative processes in addiction and reward. The role of amygdalaventralstriatal subsystems. Annals of the New York Academy of Sciences. 29:1999;412-438.
16. Fowler I.L., Carr V.J., Carter N.T., Lewin T.J. Patterns of current and life substance use in schizophrenia. Schizophrenia Bulletin. 24:1998;443-455.
17. Gurevitch E.V., Bordelon Y., Shapiro R.M., Arnold S.E., Gur R.E., Joyce J.N. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. Archives of General of Psychiatry. 54:1997;225-232.
18. Hambrecht M., Hafner H. Substance abuse and the onset of schizophrenia. Biological Psychiatry. 40:1996;1155-1163.
19. Johnson W.L., Malow R.M., Corrigan S.A., West J.A. Impulsive behavior and substance abuse. McCown W.G., Johnson J.L., Shure M.B., The Impulsive Client: Theory, Research and Treatment. 1996;225-246 American Psychological Association, Washington DC.
20. Joyce J.N., Gurevitch E.V. D3 receptors and the actions of neuroleptics in the ventral striatiopallidal system of schizophrenics. Annals of the New York Academy of Sciences. 29:1999;595-613.
21. Kay S.R., Opler L.A. Manuel de cotation de la PANSS (1986). 1988;. traduction française de J.P. Lépine.
22. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 13:1987;261-276.
23. Khantzian E.J., Treece C. DSM III psychiatric diagnosis of narcotic addicts. Archives of General Psychiatry. 42:1985;1067-1071.
24. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry. 4:1997;231-244.
25. Krebs M.O., Sautel F., Bourdel M.C., Sokoloff P., Schwartz J.C., Olié J.P., Lôo H., Poirier M.F. Dopamine D3 receptor gene variants and substance abuse in schizophrenia. Molecular Psychiatry. 3:1998;337-341.
26. Linszen D.H., Dingemans P.M., Lenior M.E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry. 51:1994;273-279.
27. Liraud F., Verdoux H. Which temperamental characteristics are associated with substance use in subjects with psychotic and mood disorders. Psychiatry Research. 93:2000;63-72.
28. May P.R., Dencker S.J., Hubbard J.W., Midha K.K., Liberman R.P. A systematic approach to treatment resistance in schizophrenic disorders. Dencker S.J., Kulhanel F., Treatment Resistance in Schizophrenia. 1988;Vieweg Verlag, Wiesbaden.
29. Mueser K.T., Yarnold P.R., Levinson D.F., Singh H., Bellack A.S., Kee K., Morrison R.L., Yadalam K.G. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophrenia Bulletin. 16:1990;31-56.
30. Mueser K.T., Yarnold P.R., Bellack A.S. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatrica Scandinavica. 85:1992;48-55.
31. Mueser K.T., Drake R.E., Ackerson T.H., Alterman A.I., Miles K.M., Noordsy D.L. Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia. Journal of Abnormal Psychology. 106:1997;473-477.
32. Räsänen P., Tiihonen J., Isohanni M., Rantakallio P., Lehtonen J., Moring J. Schizophrenia, alcohol abuse, and violent behavior: a 26-year follow-up study of an unselected birth cohort. Schizophrenia Bulletin. 24:1998;437-441.
33. Regier D., Farmer M., Rae D., Locke B., Keith S. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association. 264:1990;2511-2518.
34. Schneier F.R., Siris S.G. A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. Journal of Nervous and Mental Disease. 175:1987;641-651.
35. Shaner A., Eckman T.A., Roberts L.J., Wilkins J.N., Tucker D.E., Tsuang J., Mintz J. Disability income, cocaine use, and repeated hospitalizations among schizophrenic cocaine abusers. New England Journal of Medicine. 333:1995;777-783.
36. Staley J.K., Mash D.C. Adaptive increase in D3 receptors in the brain reward circuits of human cocaine fatalities. Journal of Neurosciences. 19:1996;6100-6106.
37. Van Ammers E.D., Douglas Sellman J., Mulder R.T. Temperament and substance abuse in schizophrenia: is there a relationship? Journal of Nervous and Mental Disease. 185:1997;283-288.
38. Verdoux H., Liraud F., Gonzales B., Assens F., Abalan F., Van Os J. Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiatrica Scandinavica. 100:1999;389-395.
39. Yung A.R., McGorry P.D. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophrenia Bulletin. 22:1996;353-370.